Alpha Cognition Inc
ACOG
Peringkat dalam Saham
#20080
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Harga Saham
$8.66
Kapitalisasi Pasar
$134.50M
Perubahan (1 hari)
1.88%
Perubahan (1 tahun)
72.17%
Negara
US
Perdagangan Alpha Cognition Inc (ACOG)
Kategori
Healthcare
Riwayat pemecahan saham untuk Alpha Cognition Inc (ACOG)
Saham Alpha Cognition Inc (simbol: ACOG) telah mengalami total 1 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Nov 05, 2024.
Satu lembar saham ACOG yang dibeli sebelum Nov 05, 2024 sekarang setara dengan 0.04 lembar saham ACOG.
Pemecahan saham terbaru terjadi pada Nov 05, 2024.
Satu lembar saham ACOG yang dibeli sebelum Nov 05, 2024 sekarang setara dengan 0.04 lembar saham ACOG.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| 2024-11-05 | 1:25 | x0.04 | x0.04 |
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
